Schedule 13G ownership disclosure
AEGLEA BIOTHERAPEUTICS INC
Security class unavailable · CUSIP: 00773J103
Event date: 2019-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 617,769
- Percent of class
- 2.1300%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-20-008697
- Form type
- SC 13G
- Filer
- Spyre Therapeutics, Inc.
- CIK
- CIK 1636282
- Filed
- Jan 30, 2020
- Reporting period
- Dec 31, 2019
- Description
- Schedule 13G beneficial ownership